Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06
Published November 22, 2017 · Recall initiated: October 30, 2017
Summary
FDA records drug Class III recall D-0082-2018, published November 22, 2017 and initiated October 30, 2017. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 744 bottles; Lot: Lot # 17P0430, Exp 05/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.
What to do
Voluntary: Firm initiated · Letter
Get an email if MECLIZINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MECLIZINE HYDROCHLORIDE
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Distributor
- Nationwide
- UPC
- 0359746121068
- Lot
- Lot # 17P0430, Exp 05/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMeclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mgApril 1, 2026
- FDAMeclizine Hydrochloride Tablets, USP, 25 mg, 50-count cartons (5 x10 unit dose), 10 Tablets per card, 5 cardsJune 15, 2022
- FDAMeclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only,April 6, 2022
- FDAUrin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, Methylene BlueNovember 22, 2017
- FDABrightFarms Baby Spinach (4 oz. and 8 oz., and 3# packages)November 22, 2017
- FDAHydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only ,November 22, 2017
Questions about this recall
Was Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06 recalled?
Yes. FDA published recall D-0082-2018 on November 22, 2017. Reported hazard: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MECLIZINE HYDROCHLORIDE. UPC: 0359746121068.